BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2021 6:30:08 AM | Browse: 295 | Download: 632
 |
Received |
|
2021-05-09 13:35 |
|
Peer-Review Started |
|
2021-05-09 13:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-06 03:29 |
|
Revised |
|
2021-08-19 18:26 |
|
Second Decision |
|
2021-09-13 02:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-09-17 02:56 |
|
Articles in Press |
|
2021-09-17 02:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-11-19 02:34 |
|
Publish the Manuscript Online |
|
2021-11-23 06:30 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Prospective Study |
| Article Title |
Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Piyatida Chuengsaman, Surapong Narenpitak and Suchai Sritippayawan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Piyatida Chuengsaman, MD, Doctor, Banphaeo Dialysis Group, Banphaeo Hospital (Public Organization), 198 Moo 1 Banphaeo, Banphaeo 74120, Samutsakhon, Thailand. pchuengsaman@gmail.com |
| Key Words |
Recombinant human erythropoietin; Anemia; Peritoneal dialysis; Chronic kidney disease; Epoetin alfa |
| Core Tip |
This was an open-label, single-arm, prospective, multicenter study of Hema-Plus®, a recombinant human erythropoietin (rHuEPO) for management of anemia in 30 Thai chronic kidney disease patients who started peritoneal dialysis with hemoglobin (Hb) lower than 9.5 g/dL and who had not previously received epoetin. The results showed that the rHuEPO could significantly increase Hb from baseline throughout the 12-wk treatment duration with acceptable safety profile. The quality of life (QoL) scores at week 12 assessed using KDQOL-36 were significantly increased from baseline in all domains. |
| Publish Date |
2021-11-23 06:30 |
| Citation |
Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 |
| URL |
https://www.wjgnet.com/2220-6124/full/v10/i6/109.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v10.i6.109 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
